Unlikely to cause harm — often a labeling or packaging issue.
Failed Dissolution Specifications: This recall is an extension of the recall initiated on 07/31/2013 for Bupropion HCl Extended-Release Tablets (XL) 300 mg, because another lot was shown to have similar failing results for dissolution at the 8-hour timepoint.
| Distributed by / for | Actavis South Atlantic, LLC, Sunrise, FL 33325; Packaged by: American Health Packaging, Columbus, OH 43217 |
| NDC | 67767-142-30 |
| Full product label | buPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, 30-count tablets per bottle, Rx only, Distributed by: Actavis South Atlantic, LLC, Sunrise, FL 33325; Packaged by: American Health Packaging, Columbus, OH 43217, NDC 67767-142-30, UPC 3 67767-142-30 6. |
| Recalling firm | Actavis South Atlantic LLC |
| Distribution | Nationwide and Puerto Rico |
| Quantity | 428,268 bottles |
| Recall initiated | 2013-08-21 |
| Report date | 2013-09-04 |
| Recall completed | 2014-04-10 |
| Recall number | D-917-2013 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Sunrise FL United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗